Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
Vericel (NASDAQ:VCEL), a leader in advanced therapies for sports medicine and severe burn care, has appointed Karen Mahoney as Chief Human Resources Officer. This follows the retirement of Heidi Hassen, who served in the role since 2010. Mahoney brings over 20 years of experience in life sciences and medical devices, most recently as CHRO at Abiomed. Her expertise includes HR strategy, talent selection, and leadership development.
Mahoney's appointment is expected to drive organizational success and support Vericel's long-term growth. She aims to foster a purpose-driven, patient-focused culture that attracts top talent. Nick Colangelo, Vericel's President and CEO, expressed confidence in Mahoney's ability to contribute to the company's continued success.
Vericel (NASDAQ:VCEL), leader nelle terapie avanzate per la medicina sportiva e la cura delle ustioni gravi, ha nominato Karen Mahoney come Chief Human Resources Officer. Questo avviene dopo il pensionamento di Heidi Hassen, che ha ricoperto il ruolo dal 2010. Mahoney porta con sé oltre 20 anni di esperienza nelle scienze della vita e nei dispositivi medici, recententemente come CHRO presso Abiomed. La sua esperienza comprende strategia HR, selezione del personale e sviluppo della leadership.
Si prevede che la nomina di Mahoney spinga al successo organizzativo e supporti la crescita a lungo termine di Vericel. La sua intenzione è quella di promuovere una cultura orientata allo scopo e focalizzata sul paziente che attragga i migliori talenti. Nick Colangelo, Presidente e CEO di Vericel, ha espresso fiducia nella capacità di Mahoney di contribuire al continuo successo dell'azienda.
Vericel (NASDAQ:VCEL), líder en terapias avanzadas para la medicina deportiva y el cuidado de quemaduras severas, ha nombrado a Karen Mahoney como Directora de Recursos Humanos. Esto ocurre tras la jubilación de Heidi Hassen, quien ocupó el cargo desde 2010. Mahoney aporta más de 20 años de experiencia en ciencias de la vida y dispositivos médicos, siendo su cargo más reciente el de CHRO en Abiomed. Su experiencia incluye estrategia de RRHH, selección de talento y desarrollo de liderazgo.
Se espera que el nombramiento de Mahoney impulse el éxito organizacional y apoye el crecimiento a largo plazo de Vericel. Su objetivo es fomentar una cultura orientada a la misión y centrada en el paciente que atraiga a los mejores talentos. Nick Colangelo, Presidente y CEO de Vericel, expresó confianza en la capacidad de Mahoney para contribuir al éxito continuo de la empresa.
Vericel (NASDAQ:VCEL)은 스포츠 의학 및 중증 화상 치료를 위한 첨단 치료 분야의 선두주자로서 Karen Mahoney를 최고 인사 책임자로 임명했습니다. 이는 2010년부터 이 역할을 수행해온 Heidi Hassen의 은퇴 이후 이루어진 것입니다. Mahoney는 최근 Abiomed의 CHRO로 재직하며 생명 과학 및 의료 기기 분야에서 20년 이상의 경험을 보유하고 있습니다. 그녀의 전문 분야는 인사 전략, 인재 선정 및 리더십 개발입니다.
Mahoney의 임명이 조직의 성공을 이끌고 Vericel의 장기 성장에 기여할 것으로 기대됩니다. 그녀는 최고의 인재를 유치하는 목적 중심의, 환자 중심 문화를 조성하는 것을 목표로 하고 있습니다. Vericel의 사장 겸 CEO인 Nick Colangelo는 Mahoney가 회사의 지속적인 성공에 기여할 수 있다는 확신을 표명했습니다.
Vericel (NASDAQ:VCEL), leader dans les thérapies avancées pour la médecine sportive et les soins des brûlures graves, a nommé Karen Mahoney au poste de Directrice des Ressources Humaines. Cela fait suite à la retraite de Heidi Hassen, qui occupait ce rôle depuis 2010. Mahoney apporte plus de 20 ans d'expérience dans les sciences de la vie et les dispositifs médicaux, ayant récemment été CHRO chez Abiomed. Son expertise comprend stratégie RH, sélection des talents et développement du leadership.
La nomination de Mahoney devrait favoriser le succès organisationnel et soutenir la croissance à long terme de Vericel. Elle vise à promouvoir une culture axée sur le sens et centrée sur le patient qui attire les meilleurs talents. Nick Colangelo, Président et CEO de Vericel, a exprimé sa confiance en la capacité de Mahoney à contribuer au succès continu de l'entreprise.
Vericel (NASDAQ:VCEL), ein führendes Unternehmen im Bereich fortschrittliche Therapien für Sportmedizin und die Behandlung schwerer Verbrennungen, hat Karen Mahoney zur Chief Human Resources Officer ernannt. Dies folgt auf die Pensionierung von Heidi Hassen, die die Position seit 2010 innehatte. Mahoney bringt über 20 Jahre Erfahrung in den Lebenswissenschaften und medizinischen Geräten mit, zuletzt als CHRO bei Abiomed. Ihre Expertise umfasst HR-Strategie, Talentauswahl und Führungskräfteentwicklung.
Es wird erwartet, dass Mahoneys Ernennung den organisatorischen Erfolg vorantreibt und das langfristige Wachstum von Vericel unterstützt. Sie hat sich zum Ziel gesetzt, eine zielorientierte, patientenfokussierte Kultur zu fördern, die die besten Talente anzieht. Nick Colangelo, Präsident und CEO von Vericel, äußerte Vertrauen in Mahoneys Fähigkeit, zum fortgesetzten Erfolg des Unternehmens beizutragen.
- Appointment of experienced CHRO with over 20 years in life sciences and medical devices
- New CHRO's background in driving talent selection and leadership development
- Potential for fresh perspectives and strengthened leadership in HR strategy
- None.
CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Karen Mahoney as Chief Human Resources Officer following the retirement of Heidi Hassen, who served as Vericel’s Head of Human Resources since September 2010.
Ms. Mahoney joins Vericel with more than 20 years of experience across the life sciences and medical device sectors, most recently serving as Chief Human Resources Officer at Abiomed, a global medical device company that was acquired by Johnson & Johnson in December 2022. At Abiomed, Ms. Mahoney led all aspects of HR strategy and operations, driving talent selection, leadership development and contributing to strong business performance across the company. Following the acquisition, Ms. Mahoney served as a key member of the integration team overseeing the transition of all HR-related programs into Johnson & Johnson. Prior to Abiomed, Ms. Mahoney held roles of increasing responsibility at PerkinElmer, culminating with her position as Global Talent Leader.
“I am delighted to welcome Karen to Vericel,” said Nick Colangelo, President and CEO of Vericel. “Karen has a strong track record of building high-performing teams and driving strong business results in high-growth organizations. I am confident that her extensive strategic and executive leadership experience in the Human Resources and medical technology fields will play an instrumental role in driving continued organizational success for Vericel in the years ahead.”
“I am honored to join Vericel and am excited for the opportunity to build upon Vericel’s strong foundation as we continue to foster a purpose-driven, patient-focused culture that attracts and retains world-class talent,” said Ms. Mahoney, Chief Human Resources Officer of Vericel. “I look forward to partnering with our talented teams to support Vericel’s long-term growth and drive continued value for our patients and our shareholders.”
Ms. Mahoney earned a B.A. in Marketing from Assumption College and her M.B.A from Suffolk University.
About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to
Epicel and MACI are registered trademarks of Vericel Corporation. NexoBrid is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2024 Vericel Corporation. All rights reserved.
Investor Contact:
Eric Burns
ir@vcel.com
+1 (734) 418-4411
Media Contact:
Julie Downs
media@vcel.com
FAQ
Who is the new Chief Human Resources Officer at Vericel (VCEL)?
What is Karen Mahoney's background before joining Vericel (VCEL)?
Why did Vericel (VCEL) appoint a new Chief Human Resources Officer?
What are the expected contributions of Karen Mahoney to Vericel (VCEL)?
